Neuroprotective effects of riluzole in Alzheimer's disease: A comprehensive review.
Golmohammadi M, Mahmoudian M, Hasan EK, Alshahrani SH, Romero-Parra RM, Malviya J, Hjazi A, Najm MAA, Almulla AF, Zamanian MY, Kadkhodaei M, Mousavi N.
Golmohammadi M, et al.
Fundam Clin Pharmacol. 2024 Apr;38(2):225-237. doi: 10.1111/fcp.12955. Epub 2023 Sep 27.
Fundam Clin Pharmacol. 2024.
PMID: 37753585
Review.
BACKGROUND: Despite several hundred clinical trials of drugs that initially showed promise, there has been limited clinical improvement in Alzheimer's disease (AD). This may be attributed to the existence of at least 25 abnormal cellular pathways that underlie the disease. …
BACKGROUND: Despite several hundred clinical trials of drugs that initially showed promise, there has been limited clinical improvement in A …